Last $71.57 USD
Change Today +1.99 / 2.86%
Volume 444.4K
INCY On Other Exchanges
Symbol
Exchange
Frankfurt
As of 5:10 PM 12/24/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Paul A. Friedman M.D.

Director, Member of Non-Management Stock Option Committee and Member of Finance Committee, Incyte Corporation
AgeTotal Calculated CompensationThis person is connected to 87 board members in 7 different organizations across 8 different industries.

See Board Relationships
71--
As of Fiscal Year 2013

Background*

Dr. Paul A. Friedman, M.D. is a Partner at Vilicus Ventures, LLC. He is also a Cardiologist and Professor at Mayo Clinic. He served as the Chief Executive Officer of Incyte Corporation from November 2001 to January 13, 2014 and also as its President from May 2004 to January 13, 2014. From 1998 to October 2001, Dr. Friedman served as the President of DuPont Pharmaceuticals Research Laboratories. From 1994 to 1998, he served as President of Research and Development of ...

Read Full Background

Corporate Headquarters*

Experimental Station
Wilmington, Delaware 19880

United States

Phone: 302-498-6700
Fax: --

Board Members Memberships*

2001-Present
Director, Member of Non-Management Stock Option Committee and Member of Finance Committee
2004-N/A
Former Director and Member of Nominating & Governance Committee
2008-N/A
Director and Member of Compensation Committee
2010-Present
Director and Member of Compensation Committee
2013-Present
Non-Executive Director
2013-Present
Director and Member of Governance & Nominating Committee
2014-Present
Director, Member of Executive Committee and Member of Compensation Committee
2014-Present
Executive Chairman, Member of Nominating & Corporate Governance Committee and Member of Compensation Committee
2014-Present
Director

Education*

BA 1964
Princeton University
MD 1969
Harvard Medical School

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
INCY:US $71.57 USD +1.99

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INCYTE CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.